Daniel Rakiec

Daniel Rakiec

Novartis Institutes for BioMedical Research - Bhubaneswar / United States
Engineering & Technology / Biomedical Engineering
AD Scientific Index ID: 4393747
-
person_outline Daniel Rakiec's MOST POPULAR ARTICLES
1-) An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide)M Korpal, JM Korn, X Gao, DP Rakiec, DA Ruddy, S Doshi, J Yuan, ...Cancer discovery 3 (9), 1030-1043, 20135762013
2-) Studying clonal dynamics in response to cancer therapy using high-complexity barcodingHC Bhang, DA Ruddy, V Krishnamurthy Radhakrishna, JX Caushi, ...Nature medicine 21 (5), 440-448, 20154112015
3-) Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphomaR Rahal, M Frick, R Romero, JM Korn, R Kridel, F Chun Chan, B Meissner, ...Nature medicine 20 (1), 87-92, 20143482014
4-) CRISPR screens provide a comprehensive assessment of cancer vulnerabilities but generate false-positive hits for highly amplified genomic regionsDM Munoz, PJ Cassiani, L Li, E Billy, JM Korn, MD Jones, J Golji, ...Cancer discovery 6 (8), 900-913, 20163942016
5-) Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR lossH Liu, J Golji, LK Brodeur, FS Chung, JT Chen, RS deBeaumont, ...Nature medicine 25 (1), 95-102, 20193072019